Editorial: Somatostatin, hormone inhibitor.
D000172:Acromegaly / Q000188:drug therapy; D000818:Animals; D005934:Glucagon / Q000097:blood; D013006:Growth Hormone / Q000037:antagonists & inhibitors*; D000882:Haplorhini; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000166:cytology / Q000187:drug effects; D010455:Peptides / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D010903:Pituitary Gland, Anterior / Q000502:physiology; D010908:Pituitary Hormones, Anterior / Q000502:physiology; D051381:Rats; D012756:Sheep; D013921:Thrombocytopenia / Q000139:chemically induced
D007328:Insulin; D010455:Peptides; D010908:Pituitary Hormones, Anterior; D013006:Growth Hormone; D005934:Glucagon